Literature DB >> 9407986

Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study.

R Broll1, V Schauer, H Schimmelpenning, M Strik, A Woltmann, R Best, H P Bruch, M Duchrow.   

Abstract

PURPOSE: Whereas lymph node metastases in colorectal carcinoma are an important prognostic factor, the prognostic relevance of occult tumor cells in lymph nodes is not elucidated at present. Therefore, our study intended to assess the rate of patients with occult tumor cells in histopathologically negative lymph nodes. Furthermore, we tried to evaluate an eventual influence of these occult tumor cells on patients' prognoses.
METHODS: For examination, we used paraffin blocks of lymph nodes, tumor-negative by conventional histopathology, from 49 patients with colorectal carcinoma (Stage I-III) after a curative (R0) tumor resection in 1987. After preparation of tissue blocks using the serial sectioning technique, the specimens were stained with the alkaline phosphatase, antialkaline phosphatase method and two monoclonal antibodies (AE1/AE3 and Ber-EP4).
RESULTS: In 13 of 49 patients (26.5 percent), we disclosed tumor cells, mostly located in subcapsular sinuses as single cells or in groups. There was a good correlation between the detection rate and N category, tumor stage, and grading. Moreover, 33 percent of patients in Stage I/II with occult tumor cells (N0+) developed a local relapse and/or distant metastases in contrast to 12 percent of patients without tumor cells (N0-). With a median follow-up of 84 months, we found no difference in disease-free survival between the tumor cell negative and positive groups in Stage I/II patients.
CONCLUSION: The results show that occult tumor cells might increase the risk for development of a local tumor relapse and/or distant metastases but do not influence patients' prognoses at all.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407986     DOI: 10.1007/bf02070713

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  24 in total

Review 1.  Nodal staging of colorectal carcinomas and sentinel nodes.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

2.  Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3.

Authors:  Zhi-Wei Zhou; Nick Rieger; Andrew Ruszkiewicz; Guo-Qiang Wang; De-Sen Wan
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 3.  Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.

Authors:  Daniel G Nicastri; John T Doucette; Tony E Godfrey; Steven J Hughes
Journal:  J Mol Diagn       Date:  2007-10-04       Impact factor: 5.568

Review 4.  Detection and clinical implications of minimal residual disease in gastro-intestinal cancer.

Authors:  Fabian Wolfrum; Ilka Vogel; Fred Fändrich; Holger Kalthoff
Journal:  Langenbecks Arch Surg       Date:  2005-07-01       Impact factor: 3.445

5.  Detection of lymph node micrometastases and isolated tumor cells in sentinel and nonsentinel lymph nodes of colon cancer patients.

Authors:  Andreas Bembenek; Ulrike Schneider; Stephan Gretschel; Joerg Fischer; Peter M Schlag
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

6.  Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size.

Authors:  Carsten T Viehl; Christian T Hamel; Walter R Marti; Ulrich Guller; Lukas Eisner; Uz Stammberger; Luigi Terracciano; Hans P Spichtin; Felix Harder; Markus Zuber
Journal:  World J Surg       Date:  2003-11-06       Impact factor: 3.352

7.  Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.

Authors:  C Milsmann; L Füzesi; E Heinmöller; P Krause; C Werner; H Becker; O Horstmann
Journal:  Langenbecks Arch Surg       Date:  2007-09-18       Impact factor: 3.445

8.  [Optimization of staging in colon cancer using sentinel lymph node biopsy].

Authors:  A Bembenek; U Schneider; S Gretschel; C Ulmer; P M Schlag
Journal:  Chirurg       Date:  2005-01       Impact factor: 0.955

9.  Previstage GCC test for staging patients with colorectal cancer.

Authors:  Alex Mejia; Scott A Waldmana
Journal:  Expert Rev Mol Diagn       Date:  2008-09       Impact factor: 5.225

Review 10.  Sentinel lymph node biopsy progress in surgical treatment of cancer.

Authors:  T Schulze; A Bembenek; P M Schlag
Journal:  Langenbecks Arch Surg       Date:  2004-06-09       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.